Ke-nan Zhang

Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Aggressive resection of non-contrast-enhanced tumor provides varying benefits to glioblastoma, IDH-wildtype patients based on different clinical characteristics.

Aggressive resection of non-contrast-enhanced tumor provides varying benefits to glioblastoma, IDH-wildtype patients based on different clinical characteristics.

Journal: Cancer letters
Published: November 07, 2024

circRNADisease v2.0: an updated resource for high-quality experimentally supported circRNA-disease associations.

circRNADisease v2.0: an updated resource for high-quality experimentally supported circRNA-disease associations.

Journal: Nucleic acids research
Published: September 09, 2023

Corrigendum to "METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma" [Canc. Lett. 511 (2021) 36-46].

Corrigendum to "METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma" [Canc. Lett. 511 (2021) 36-46].

Journal: Cancer letters
Published: July 22, 2023

MET fusions and splicing variants is a strong adverse prognostic factor in astrocytoma, isocitrate dehydrogenase mutant.

MET fusions and splicing variants is a strong adverse prognostic factor in astrocytoma, isocitrate dehydrogenase mutant.

Journal: Brain pathology (Zurich, Switzerland)
Published: April 08, 2023

Molecular and clinical characterization of PTRF in glioma via 1,022 samples.

Molecular and clinical characterization of PTRF in glioma via 1,022 samples.

Journal: BMC cancer
Published: January 30, 2023

Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.

Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.

Journal: Brain pathology (Zurich, Switzerland)
Published: December 26, 2022

WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System.

WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System.

Journal: Scientific data
Published: April 21, 2022

YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma.

YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma.

Journal: Journal of hematology & oncology
Published: May 06, 2021

METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.

METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.

Journal: Cancer letters
Published: March 01, 2021

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas.

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas.

Journal: Frontiers in cell and developmental biology
Published: July 06, 2020

RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.

RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.

Journal: JCI insight
Published: August 14, 2019

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy.

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy.

Journal: OncoTargets and therapy
Published: July 19, 2019
Showing 1-12 of 21

Last Updated: 09/26/2026